Since measuring RB1 expression is a current standard method to determine RB1 status in clinical samples, we analyzed RB1 and CCND1/CDKN2A mRNA expression levels in 6 SCLC and 17 normal lung samples using publicly available microarray data (Additional file 3). The gene discussed is CDKN2A; the disease is small cell lung carcinoma.